In addition, LRRK2 promotes tumor cell growth and survival in papillary renal and in thyroid carcinomas [49] and proliferation together with metastatic capacity in intrahepatic cholangiocarcinoma cells [50]. This evidence concerns the gene LRRK2 and cholangiocarcinoma.